Professor Shelley Dolan
BA (Hons), MSc, PhD
Professor Shelley Dolan joined the RMH in August 2023 as Chief Executive. She is a familiar face in the Parkville Precinct, previously serving as the Chief Executive of the Peter MacCallum Cancer Centre.
In her previous roles, Professor Dolan has successfully led large specialist tertiary hospitals in the UK, including as Chief Executive of Kings College Hospital, London and Deputy Chief Executive of the Royal Marsden Hospital.
Professor Dolan is a highly respected clinical and research leader with an impressive track record in health care, having successfully led major organisational and cultural change in Australia, Europe and the UK.
Key capabilities include executive and non-executive leadership across national and international bodies, strategy development, delivering excellence in quality and performance, overseeing large capital schemes and innovative research projects that require engagement with a broad range of stakeholders.
Professor Shelley Dolan has a PhD in the early diagnosis of sepsis and a masters degree in advanced practice. She is a Professor (Enterprise) of the Melbourne School of Health Science at the University of Melbourne.
She is a Board Member of the Melbourne Academic Centre for Health, Melbourne Genomics, the Peter Doherty Institute and the Walter and Eliza Hall Institute, Member of the Centre for Digital Transformation of Health and CRC Participant Director on the Board of Oncology One.
In November 2022, the Federal Minister for Health and Aged Care appointed Professor Dolan as a Member of the Cancer Australia Advisory Council.
